XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Dow Consolidated Statements of Income Statement - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 10,730 $ 14,115 $ 34,001 $ 45,043
Cost of sales 9,592 12,381 30,096 37,682
Research and development expenses 197 191 616 626
Selling, general and administrative expenses 380 356 1,216 1,289
Amortization of intangibles 81 83 243 256
Restructuring and asset related charges - net 0 0 549 186
Equity in earnings (losses) of nonconsolidated affiliates (7) (58) (112) 311
Sundry income (expense) - net 92 69 202 292
Interest income 44 41 186 105
Interest expense and amortization of debt discount 192 155 549 487
Income before income taxes 417 1,001 1,008 5,225
Provision for income taxes 90 241 253 1,232
Net income 327 760 755 3,993
Net income attributable to noncontrolling interests 25 21 61 24
Net income available for The Dow Chemical Company common stockholder $ 302 $ 739 $ 694 $ 3,969
Earnings per common share - basic $ 0.43 $ 1.03 $ 0.97 $ 5.45
Earnings per common share - diluted $ 0.42 $ 1.02 $ 0.97 $ 5.41
Weighted-average common shares outstanding - basic 704.0 714.3 706.4 724.9
Weighted-average common shares outstanding - diluted 707.5 718.1 709.7 729.8